Trials / Conditions / Advanced or Metastatic Solid Tumor

Advanced or Metastatic Solid Tumor

8 registered clinical trials studyying Advanced or Metastatic Solid Tumor — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation NCT06117371	BeBetter Med Inc	Phase 1
Unknown	The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumo NCT05263986	Zai Lab (Shanghai) Co., Ltd.	Phase 1
Recruiting	Treatment of Advanced and Metastatic Solid Tumors With MIL97 NCT04965077	Beijing Mabworks Biotech Co., Ltd.	Phase 1
Recruiting	AB122 Platform Study NCT04999761	Taiho Pharmaceutical Co., Ltd.	Phase 1
Unknown	Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist o NCT04327583	Institut Cancerologie de l'Ouest	N/A
Recruiting	Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impa NCT04617522	Gilead Sciences	Phase 1
Terminated	Futibatinib in Patients With Specific FGFR Aberrations NCT04189445	Taiho Oncology, Inc.	Phase 2
Completed	Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Rece NCT03517956	Bayer	Phase 1